Distinct effects of resveratrol on seizures and hyperexcitability induced by NMDA and 4-aminopyridine

References

• Shetty AK. Promise of resveratrol for easing status epilepticus and epilepsy. Pharmacol Ther. 2011;131(3):269–86.
   PubMed Web of Science ®Google Scholar
• Meng XJ, Wang F, Li CK. Resveratrol is neuroprotective and improves cognition in pentylenetetrazole-kindling model of epilepsy in rats. Indian J Pharm Sci. 2014;76(2):125–31.
   PubMed Web of Science ®Google Scholar
• Gupta YK, Briyal S, Chaudhary G. Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats. Pharmacol Biochem Behav. 2002;71(1–2):245–9.
   PubMed Web of Science ®Google Scholar
• Gupta YK, Chaudhary G, Sinha K, Srivastava AK. Protective effect of resveratrol against intracortical FeCl3-induced model of posttraumatic seizures in rats. Methods Find Exp Clin Pharmacol. 2001;23(5):241–4.
   PubMedGoogle Scholar
• Tomaciello F, Leclercq K, Kaminski RM. Resveratrol lacks protective activity against acute seizures in mouse models. Neurosci Lett. 2016;632:199–203.
   PubMed Web of Science ®Google Scholar
• Sanchez JT, Seidl AH, Rubel EW, Barria A. Control of neuronal excitability by NMDA-type glutamate receptors in early developing binaural auditory neurons. J Physiol. 2012;590(19):4801–18.
   PubMed Web of Science ®Google Scholar
• Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol 2008;7(8):742–55.
   PubMed Web of Science ®Google Scholar
• Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr. 2011;11(2):56–63.
   PubMed Web of Science ®Google Scholar
• Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev. 1999;51(1):7–61.
   PubMed Web of Science ®Google Scholar
• Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure. 2015;30:14–20.
   PubMed Web of Science ®Google Scholar
• Dhir A, Chopra K. Memantine delayed N-methyl-D-aspartate -induced convulsions in neonatal rats. Fundam Clin Pharmacol. 2015;29(1):72–8.
   PubMed Web of Science ®Google Scholar
• Birnbaum SG, Varga AW, Yuan LL, Anderson AE, Sweatt JD, Schrader LA. Structure and function of Kv4-family transient potassium channels. Physiol Rev. 2004;84(3):803–33.
   PubMed Web of Science ®Google Scholar
• Villa C, Combi R. Potassium channels and human epileptic phenotypes: an updated overview. Front Cell Neurosci. 2016;10:81.
   PubMed Web of Science ®Google Scholar
• Gao ZB, Chen XQ, Hu GY. Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus. Brain Res. 2006;1111(1):41–47.
   PubMedGoogle Scholar
• Gao ZB, Hu GY. Trans-resveratrol, a red wine ingredient, inhibits voltage-activated potassium currents in rat hippocampal neurons. Brain Res. 2005;1056(1):68–75.
   PubMed Web of Science ®Google Scholar
• Teisseyre A, Michalak K. Inhibition of the activity of human lymphocyte Kv1.3 potassium channels by resveratrol. J Membr Biol. 2006;214(3):123–9.
   PubMed Web of Science ®Google Scholar
• Dong WH, Chen JC, He YL, Xu JJ, Mei YA. Resveratrol inhibits K(v)2.2 currents through the estrogen receptor GPR30-mediated PKC pathway. Am J Physiol Cell Physiol. 2013;305(5):C547–57.
   PubMed Web of Science ®Google Scholar
• Novakovic A, Bukarica LG, Kanjuh V, Heinle H. Potassium channels-mediated vasorelaxation of rat aorta induced by resveratrol. Basic Clin Pharmacol Toxicol. 2006;99(5):360–4.
   PubMed Web of Science ®Google Scholar
• Gojkovic-Bukarica L, Novakovic A, Kanjuh V, Bumbasirevic M, Lesic A, Heinle H. A role of ion channels in the endothelium-independent relaxation of rat mesenteric artery induced by resveratrol. J Pharmacol Sci. 2008;108(1):124–30.
   PubMed Web of Science ®Google Scholar
• Chan MH, Chen HH. Toluene exposure increases aminophylline-induced seizure susceptibility in mice. Toxicol Appl Pharmacol. 2003;193(2):303–8.
   PubMed Web of Science ®Google Scholar
• Lee MY, Lin YR, Tu YS, Tseng YJ, Chan MH, Chen HH. Effects of sarcosine and N, N-dimethylglycine on NMDA receptor-mediated excitatory field potentials. J Biomed Sci 2017;24(1):191.
   Google Scholar
• Wang YJ, Chan MH, Chen L, Wu SN, Chen HH. Resveratrol attenuates cortical neuron activity: roles of large conductance calcium-activated potassium channels and voltage-gated sodium channels. J Biomed Sci 2016;23(1):27.
   PubMedGoogle Scholar
• Ghasemi M, Schachter SC. The NMDA receptor complex as a therapeutic target in epilepsy: a review. Epilepsy Behav. 2011;22(4):617–40.
   PubMed Web of Science ®Google Scholar
• Yen W, Williamson J, Bertram EH, Kapur J. A comparison of three NMDA receptor antagonists in the treatment of prolonged status epilepticus. Epilepsy Res. 2004;59(1):43–50.
   PubMed Web of Science ®Google Scholar
• Zaitsev AV, Kim K, Vasilev DS, Lukomskaya NY, Lavrentyeva VV, Tumanova NL, et al. N-methyl-D-aspartate receptor channel blockers prevent pentylenetetrazole-induced convulsions and morphological changes in rat brain neurons. J Neurosci Res. 2015;93(3):454–65.
   PubMed Web of Science ®Google Scholar
• Zeiler FA. Early use of the NMDA receptor antagonist ketamine in refractory and superrefractory status epilepticus. Crit Care Res Pract. 2015;2015:831260.
   PubMedGoogle Scholar
• Schauwecker PE. Neuroprotection by glutamate receptor antagonists against seizure-induced excitotoxic cell death in the aging brain. Exp Neurol. 2010;224(1):207–18.
   PubMed Web of Science ®Google Scholar
• Mathern GW, Pretorius JK, Mendoza D, Lozada A, Leite JP, Chimelli L, et al. Increased hippocampal AMPA and NMDA receptor subunit immunoreactivity in temporal lobe epilepsy patients. J Neuropathol Exp Neurol. 1998;57(6):615–34.
   PubMed Web of Science ®Google Scholar
• Möddel G, Jacobson B, Ying Z, Janigro D, Bingaman W, González-Martínez J, et al. The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia. Brain Res. 2005;1046(1–2):10–23.
   PubMed Web of Science ®Google Scholar
• Chen Q, He S, Hu XL, Yu J, Zhou Y, Zheng J, et al. Differential roles of NR2A- and NR2B-containing NMDA receptors in activity-dependent brain-derived neurotrophic factor gene regulation and limbic epileptogenesis. J Neurosci. 2007;27(3):542–52.
   PubMed Web of Science ®Google Scholar
• Mishra V, Shuai B, Kodali M, Shetty GA, Hattiangady B, Rao X, et al. Resveratrol treatment after status epilepticus restrains neurodegeneration and abnormal neurogenesis with suppression of oxidative stress and inflammation. Sci Rep 2015;5:17807.
   PubMed Web of Science ®Google Scholar
• Pallas M, Ortuno-Sahagun D, Andres-Benito P, Ponce-Regalado MD, Rojas-Mayorquin AE. Resveratrol in epilepsy: preventive or treatment opportunities? Front Biosci (Landmark Ed). 2014;19:1057–64.
   PubMed Web of Science ®Google Scholar
• McCalley AE, Kaja S, Payne AJ, Koulen P. Resveratrol and calcium signaling: molecular mechanisms and clinical relevance. Molecules. 2014;19(6):7327–40.
   PubMed Web of Science ®Google Scholar
• Rho JM, Szot P, Tempel BL, Schwartzkroin PA. Developmental seizure susceptibility of kv1.1 potassium channel knockout mice. Dev Neurosci. 1999;21(3–5):320–7.
   PubMed Web of Science ®Google Scholar
• Brew HM, Gittelman JX, Silverstein RS, Hanks TD, Demas VP, Robinson LC, et al. Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons. J Neurophysiol. 2007;98(3):1501–25.
   PubMed Web of Science ®Google Scholar
• Jorge BS, Campbell CM, Miller AR, Rutter ED, Gurnett CA, Vanoye CG, et al. Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility. Proc Natl Acad Sci U S A. 2011;108(13):5443–8.
   PubMed Web of Science ®Google Scholar
• Barnwell LF, Lugo JN, Lee WL, Willis SE, Gertz SJ, Hrachovy RA, et al. Kv4.2 knockout mice demonstrate increased susceptibility to convulsant stimulation. Epilepsia. 2009;50(7):1741–51.
   PubMed Web of Science ®Google Scholar
• Bernard C, Anderson A, Becker A, Poolos NP, Beck H, Johnston D. Acquired dendritic channelopathy in temporal lobe epilepsy. Science. 2004;305(5683):532–5.
   PubMed Web of Science ®Google Scholar
• Peters HC, Hu H, Pongs O, Storm JF, Isbrandt D. Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci 2005;8(1):51–60.
   PubMed Web of Science ®Google Scholar
• Simons C, Rash LD, Crawford J, Ma L, Cristofori-Armstrong B, Miller D, et al. Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy. Nat Genet. 2015;47(1):73–77.
   PubMed Web of Science ®Google Scholar
• Gale K. Subcortical structures and pathways involved in convulsive seizure generation. J Clin Neurophysiol. 1992;9(2):264–77.
   PubMed Web of Science ®Google Scholar